Mazdutide

Mazdutide is a dual GLP-1 and glucagon receptor agonist evaluated in controlled metabolic trials. China approved a particular product; this does not approve a research vial in the United States.

Open calculator Explore the research

Generic research visual — not a commercial product

Compound typeGLP-1/glucagon receptor agonist peptide

Evidence basePhase 3 randomized trials in China; jurisdiction-specific approval

Regulatory contextNMPA-approved in China / No FDA-approved mazdutide product

Page purposeResearch and calculation

Compound calculator

Mazdutide reconstitution calculator

Enter the values printed on your vial and the liquid volume you added to calculate concentration, liquid volume, and the corresponding mark on a U-100 syringe scale.

Your Mazdutide calculation appears here

Enter the three required values to see the mathematical result.

This calculator performs arithmetic using values you enter. It does not select or recommend an amount, schedule, treatment, preparation method, or method of administration.

Research overview

What is Mazdutide?

Mazdutide is a modified peptide designed to engage both the GLP-1 and glucagon receptors. The studied manufactured investigational product, a particular product approved by China’s NMPA, and a supplier research vial are three distinct quality and regulatory contexts.

What has research examined?

The randomized GLORY-1 trial in 610 Chinese adults with overweight or obesity found substantially greater mean body-weight reductions with studied mazdutide than placebo; gastrointestinal adverse events were common. Innovent reported NMPA approval of its product for chronic weight management in China. Neither clinical results nor Chinese approval establish FDA approval or the identity, purity, or suitability of any differently sourced powder.

Important limitation

Trial participants and product manufacturing were controlled. Cardiometabolic endpoints and jurisdiction-specific approval cannot be generalized to unregulated research material; this page offers no amount, schedule, preparation, or treatment instruction.

Research references

Once-weekly mazdutide in Chinese adults with obesity or overweight (GLORY-1)New England Journal of Medicine
Innovent announcement of China NMPA approval for weight managementInnovent Biologics; regulatory announcement

Calculation boundary

The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.